Company Monitoring Page for Otsuka

latest headlines for company on cafepharma

The top 10 patent losses of 2015
Fierce Pharma
Fri, 12/19/14 - 08:35 am
Tags:
patents, Lantus, Abilify, Copaxone, Neulasta, Tracleer, Namenda, Avodart, Jalyn, Zyvox, Androgel, Synagis, Sanofi, Bristol-Myers Squibb, Otsuka, Teva Pharmaceutical, Amgen, Actelion, Actavis, GSK, Pfizer, AbbVie, AstraZeneca
Drug makers face another $65 billion patent cliff
Marketwatch
Wed, 12/10/14 - 05:37 pm
Tags:
patents, patent cliff, Pfizer, Otsuka, AstraZeneca, Bristol-Myers Squibb
Otsuka May Have Undervalued Avanir’s (AVNR) Bid; Shareholders Worried
Bidness Etc.
Fri, 12/5/14 - 11:01 am
Tags:
Otsuka, M&A, Avanir
Japan’s Otsuka to buy U.S. drug maker Avanir for $3.5 billion
Fortune
Tue, 12/2/14 - 08:39 am
Tags:
Otsuka, M&A, Avanir
Bristol-Myers, Otsuka ask judge to nix Abilify kickback suit
Fierce Pharma
Mon, 10/13/14 - 10:26 am
Tags:
Bristol-Myers Squibb, Otsuka, kickbacks, Abilify, whistleblower lawsuits
TB Drug Fighting Resistant Strains Wins Europe Approval
Bloomberg
Wed, 04/30/14 - 08:59 am
Tags:
TB, Europe, Otsuka, Deltyba, tuberculosis
Otsuka Pharmaceutical Completes Acquisition of Astex Pharmaceuticals
Pharmiweb
Sat, 10/12/13 - 12:02 pm
Tags:
Otsuka, Astex, M&A
Lundbeck, Otsuka start trials for Alzheimer's drug
Reuters
Thu, 10/10/13 - 08:31 am
Tags:
Otsuka, Lundbeck, Alzheimer's disease, Lu AE58054
Biotech Buyout Celebration or Raw Deal?
Motley Fool
Sat, 10/5/13 - 09:55 am
Tags:
Astex, Otsuka, M&A
Astex Pharma shareholder opposes $886 mln bid by Otsuka
Yahoo/Reuters
Thu, 10/3/13 - 09:08 am
Tags:
Astex, Otsuka, shareholders, M&A
CHMP thumbs up for 11 new drugs
Pharma Times, UK
Mon, 09/23/13 - 09:33 am
Tags:
Europe, drug approvals, Kadcyla, Roche, Bayer, Xofigo, Abilify Maintena, Otsuka, Lundbeck, Memantine Accord, Accord Healthcare, Levodopa Carbidopa Entacapone Sandoz, Orion, Vitekta, Gilead, Janssen-Cilag, Invokana, Novo Nordisk, NovoEight, AstraZeneca, Fluenz Tetra, GSK, Relvar Ellipta, Lidocaine/Prilocaine Plethora, Plethora Solutions
Lundbeck, Otsuka get positive opinion for schizophrenia drug
Reuters
Fri, 09/20/13 - 09:42 am
Tags:
Otsuka, Lundbeck, Europe, schizophrenia, Abilify Maintena
Astex Sued by Shareholder Over $886 Million Otsuka Bid
Bloomberg
Fri, 09/13/13 - 03:44 pm
Tags:
Astex, shareholders, Otsuka, M&A
This Week in Biotech
Motley Fool
Sun, 09/8/13 - 11:09 am
Tags:
Astex, Otsuka, Rockwell Medical, Theravance, GSK, Cytokinetics, Amgen
Japan's Otsuka to buy Astex Pharma for about $900 million
Reuters
Wed, 09/4/13 - 05:33 pm
Tags:
Japan, M&A, Otsuka, Astex
Otsuka's tolvaptan gets priority review at FDA
Pharma Times, UK
Mon, 04/15/13 - 09:36 am
Tags:
Tolvaptan, Otsuka, FDA, autosomal dominant polycystic kidney disease
Firm ranks top 5 biotech deals in evolving pharma R&D landscape
Fierce Biotech
Fri, 04/12/13 - 01:56 pm
Tags:
biotech, M&A, Otsuka, Lundbeck, Gilead, Macrogenics, Roche, Chiasma, Edison Pharma, Dainippon, Moderna, AstraZeneca
Alzheimer's Drug Race Heats Up With Lundbeck Deal
Investors.com
Wed, 03/27/13 - 09:52 am
Tags:
Lundbeck, Alzheimer's disease, Otsuka, Lu AE58054
Otsuka to Pay Lundbeck $825 Million for Alzheimer’s Drug
Bloomberg
Tue, 03/26/13 - 10:15 am
Tags:
Otsuka, Alzheimer's disease, Lu AE58054
Otsuka, Lundbeck Win Approval for Monthly Abilify Shot
Bloomberg
Fri, 03/1/13 - 11:12 am
Tags:
schizophrenia, Lundbeck, Otsuka, Abilify, Abilify Maintena

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.